As of May 2025, RGX-202 displayed favourable safety, with no serious adverse events (SAEs) and adverse events of special ...
REGENXBIO completes pivotal enrollment and initiates commercial production in Duchenne gene therapy programme: Rockville, Maryland Friday, October 31, 2025, 18:00 Hrs [IST] REGENX ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Almost two decades after the original movie upcoming sequel I Am Legend 2 is officially in the ...
Every time BI publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from Business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results